Mallika Singh

Company: Revolution Medicines
Job title: VP, Translational Research
Seminars:
Targeting RAS Mutant GI Cancers – Treatment Strategies and Resistance Mechanisms 9:30 am
Unmet medical need in RAS mutant GI cancers RAS(ON) Targeted Therapies for RAS mutant GI cancers: mutantselective and RASMulti inhibitors Application of biomarker-driven combination strategiesRead more
day: Day Two